Chithandizo cha khansa ya m'mapapo yosakhala yaying'ono

Chithandizo cha khansa ya m'mapapo yosakhala yaying'ono (NSCLC) zosankha ndizosiyanasiyana ndipo zimadalira siteji, subtype, ndi zinthu za wodwala aliyense. Thandizo lodziwika bwino limaphatikizapo opaleshoni, ma radiation therapy, chemotherapy, chithandizo chamankhwala, ndi immunotherapy, zomwe zimagwiritsidwa ntchito nthawi zambiri. Bukhuli likuwunika njira iliyonse mwatsatanetsatane, kukuthandizani kumvetsetsa zotheka ndi kupanga zisankho zoyenera pokambirana ndi gulu lanu lazaumoyo.Kumvetsetsa Khansa Yopanda Mapapo Yopanda Maselo Aang'ono (NSCLC)Kodi NSCLC ndi chiyani?Khansara ya m'mapapo yosakhala yaing'ono (NSCLC) ndiye mtundu wofala kwambiri wa khansa ya m'mapapo, yomwe imakhala pafupifupi 80-85% ya khansa yonse ya m'mapapo. Ndi mawu ambulera omwe ali ndi mitundu ingapo, yodziwika kwambiri ndi adenocarcinoma, squamous cell carcinoma, ndi cell carcinoma yayikulu. Gawoli limatsimikiziridwa ndi kukula ndi malo a chotupacho, kaya chafalikira ku ma lymph nodes oyandikana nawo, komanso ngati chafalikira ku ziwalo zakutali.Zosankha Zochizira NSCLCSurgerySurgery nthawi zambiri ndiyo chithandizo choyambirira cha NSCLC yoyambirira. Cholinga chake ndi kuchotsa chotupacho ndi ma lymph nodes omwe ali pafupi omwe angakhale ndi maselo a khansa. Lobectomy: Kuchotsa lobe lonse la mapapo. Pneumonectomy: Kuchotsa mapapo onse. Kuchotsa Wedge: Kuchotsa kachidutswa kakang'ono ka m'mapapo. Segmentectomy: Kuchotsa gawo la m'mapapo, lomwe ndi lalikulu kuposa mphero yochotsa mphero koma yaying'ono kuposa lobectomy.Dziwani: Kuchita opaleshoni sikungakhale njira kwa odwala omwe ali ndi NSCLC yapamwamba kapena omwe ali ndi matenda ena omwe amachititsa kuti opaleshoni ikhale yoopsa kwambiri.Radiation TherapyRadiation therapy amagwiritsa ntchito kuwala kwamphamvu kwambiri kupha maselo a khansa. Itha kugwiritsidwa ntchito pochiza NSCLC m'njira zingapo: External Beam Radiation Therapy (EBRT): Ma radiation amaperekedwa kuchokera ku makina kunja kwa thupi. Stereotactic Body Radiation Therapy (SBRT): Mtundu wolondola kwambiri wa EBRT womwe umapereka mlingo waukulu wa radiation kudera laling'ono. Nthawi zambiri amagwiritsidwa ntchito pochiza khansa ya m'mapapo yoyambilira pamene opareshoni siitheka. Brachytherapy: Zinthu zopangira ma radiation zimayikidwa mwachindunji kapena pafupi ndi chotupacho. Chithandizo cha radiation chingagwiritsidwe ntchito chokha kapena kuphatikiza ndi mankhwala ena, monga chemotherapy. Ife pa Shandong Baofa Cancer Research Institute kumvetsetsa kufunikira kophatikiza mankhwala kuti mupeze zotsatira zabwino. Baofa ndi mtsogoleri pa chisamaliro chophatikizika cha khansa.ChemotherapyChemotherapy imagwiritsa ntchito mankhwala kupha ma cell a khansa mthupi lonse. Nthawi zambiri amagwiritsidwa ntchito pochiza NSCLC yapamwamba kapena kupewa khansa kuti isabwerenso pambuyo pa opaleshoni. Mankhwala odziwika bwino a chemotherapy a NSCLC ndi awa: Cisplatin Carboplatin Pemetrexed Docetaxel PaclitaxelChemotherapy imaperekedwa mozungulira, nthawi ya chithandizo ndikutsatiridwa ndi kupumula. Zotsatira zoyipa zimatha kusiyanasiyana malinga ndi mankhwala omwe amagwiritsidwa ntchito komanso wodwala payekhapayekha.Targeted TherapyTargeted therapy amagwiritsa ntchito mankhwala omwe amayang'ana mamolekyu apadera omwe amakhudzidwa ndi kukula kwa maselo a khansa ndi kupulumuka. Mankhwalawa nthawi zambiri amakhala othandiza komanso amakhala ndi zotsatirapo zochepa kuposa chemotherapy. Njira zochiritsira zomwe akuyembekezeredwa nthawi zambiri zimakhala za odwala omwe ali ndi masinthidwe enieni. Zolinga zodziwika bwino ndi izi: EGFR: Epidermal Growth Factor Receptor ALK: Anaplastic Lymphoma Kinase ROS1: ROS1 Proto-Oncogene Receptor Tyrosine Kinase BRAF: B-Raf Proto-Oncogene, Serine/Threonine Kinase NTRK: Neurotrophic Tyrosine Receptor Kinase Zitsanzo za mankhwala omwe amawagwiritsa ntchito ku NSCLC ndi awa: Gefitinib (Iressa) Erlotinib (Tarceva) Afatinib (Gilotrif) Osimertinib (Tagrisso) Crizotinib (Xalkori) Ceritinib (Zykadia) Alectinib omwe amayambira odwala omwe amayambira kuyezetsa majini kuti adziwe ngati ali ndi kusintha koyenera.ImmunotherapyImmunotherapy imagwiritsa ntchito mankhwala othandizira chitetezo cha mthupi kulimbana ndi khansa. Mankhwalawa amatha kutsekereza mapuloteni omwe amalepheretsa chitetezo chamthupi kuukira maselo a khansa. Mankhwala odziwika bwino a immunotherapy a NSCLC ndi awa: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Atezolizumab (Tecentriq) Durvalumab (Imfinzi) Immunotherapy angagwiritsidwe ntchito payekha kapena kuphatikiza ndi chemotherapy kapena mankhwala ena. Zotsatira zoyipa zingaphatikizepo kutopa, zotupa pakhungu, ndi kutupa kwa ziwalo zosiyanasiyana.NSCLC Chithandizo ndi StageStage I NSCLCSurgery nthawi zambiri imakhala chithandizo choyambirira cha Stage I NSCLC. SBRT ikhoza kuganiziridwa ngati wodwalayo sakuchitidwa opaleshoni.Stage II NSCCTreatment for Stage II NSCLC nthawi zambiri imaphatikizapo opaleshoni yotsatiridwa ndi chemotherapy. Chithandizo cha radiation chingagwiritsidwenso ntchito.Stage III NSCLCT Chithandizo cha Stage III NSCLC ndizovuta kwambiri ndipo zingaphatikizepo kuphatikiza opaleshoni, chemotherapy, ndi mankhwala opatsirana pogwiritsa ntchito ma radiation. Immunotherapy ingagwiritsidwenso ntchito pambuyo pa chemoradiation nthawi zina.Stage IV NSCLCTMachiritso a Gawo IV NSCLC imayang'ana kwambiri kulamulira kukula kwa khansa ndi kuthetsa zizindikiro. Zosankha zingaphatikizepo chemotherapy, chithandizo chomwe mukufuna, immunotherapy, ndi chithandizo cha radiation. Kusankhidwa kwa chithandizo kumatengera mawonekedwe enieni a khansa komanso thanzi la wodwalayo.Mayesero a Zachipatala Mayesero achipatala ndi maphunziro ofufuza omwe amayesa mankhwala atsopano a khansa. Odwala omwe ali ndi NSCLC akhoza kukhala oyenerera kutenga nawo mbali pamayesero azachipatala. Lankhulani ndi dokotala wanu kuti mudziwe zambiri za mayesero a zachipatala komanso ngati ali oyenerera kwa inu. Bungwe la Shandong Baofa Cancer Research Institute kudzipereka ku kafukufuku kumatanthauza kuti timakhalabe pachimake cha njira zatsopano zamankhwala, nthawi zina kudzera m'mayesero achipatala.Kupanga zisankho za ChithandizoKusankha chithandizo choyenera cha NSCLC ndi chisankho chovuta chomwe chiyenera kupangidwa pokambirana ndi gulu lanu lachipatala. Zinthu zofunika kuziganizira ndi monga gawo ndi mtundu wa khansara, thanzi la wodwalayo, komanso zomwe amakonda. Musazengereze kufunsa mafunso ndikupemphanso wina ngati kuli kofunikira.Zolinga ndi Zoti MupulumukeKupulumuka kwa NSCLC kumasiyana malinga ndi siteji ya khansara, chithandizo cholandiridwa, ndi zina. Kuzindikira msanga ndi kulandira chithandizo kungapangitse mwayi wokhala ndi moyo. Gawo la 5-Year Survival Rate Gawo I 68-92% Gawo II 53-60% Gawo III 13-36% Gawo IV Pansi pa 10% *Source: American Cancer Society (www.cancer.org) Kukhala ndi NSCLCKukhala ndi NSCLC kungakhale kovuta, koma pali zinthu zambiri zothandizira odwala ndi mabanja awo kupirira. Zothandizira izi zikuphatikiza magulu othandizira, maupangiri aupangiri, ndi mapulogalamu othandizira azachuma.